
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CRISP-1 CRISPR/Cas9 KO Plasmid (h) | sc-406818 | 20 µg | $397.00 |
CRISP1 encodes cysteine-rich secretory protein 1 (CRISP-1), a secreted member of the CAP (cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1) superfamily with roles in reproductive tract physiology. CRISP-1 is associated with sperm maturation and functional interactions at the sperm surface, influencing processes linked to capacitation, motility regulation, and gamete interaction. Through its conserved cysteine-rich domains, CRISP-1 can participate in extracellular protein–protein interactions and modulation of ion channel activity reported for related CRISP family members, connecting it to signaling events that shape sperm function. Altered CRISP1 expression has been investigated in the context of male reproductive phenotypes and infertility-associated molecular profiles, supporting its use as a marker and mechanistic node in reproductive biology studies.
CRISP-1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CRISP1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the CRISP1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the CRISP1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish CRISP-1 protein expression.
This CRISPR knockout system enables efficient generation of CRISP1-deficient cell models for investigation of CRISP-1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.